Multiple myeloma is a cancer of the plasma cells – white blood cells that fight disease and infections.
Although patients are living longer than ever before thanks to medical advances, multiple myeloma remains an incurable disease.
Clinician-scientist Dr. Florian Kuchenbauer aims to pioneer a world-leading multiple myeloma research program at BC Cancer so that treatments can be more effective for patients who need them most.
Dr. Kuchenbauer’s success in myeloma research depends upon sustainable, dedicated support from generous donors. Start-up funding is critical for assembling all necessary lab equipment and infrastructure, and the recruitment of a world-class team.
Philanthropic funding for early “proof-of-concept” scientific work is also crucial for eligibility to national funding bodies and applying for government grants to sustain subsequent investigations on a much larger scale.
Dr. Kuchenbauer’s work at BC Cancer will look at three key treatment areas:
In order to develop these treatment areas, Dr. Kuchenbauer and his team will need to build a strong foundation to conduct their research. They will:
In order to help patients, new treatment options developed and studied in the lab must be delivered quickly to the clinic. Dr. Kuchenbauer and his team will launch clinical trials with a coordinated, efficient approach to enrollment that will give more choices to patients facing multiple myeloma.
With your help, building multiple myeloma research capacity and scientific leadership will ensure a rapid transition from knowledge to practice and will bring the hope of new, more effective treatment options to people living with the disease.